Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, works by slowing stomach emptying and activating GLP-1 receptors in the brain to reduce hunger signals. Unlike some medications, semaglutide cannot be dosed once monthly and still maintain therapeutic effectiveness for weight management. Understanding the correct dosing schedule is essential for achieving consistent results.
How Wegovy Dosing Actually Works
Wegovy follows a 16-week titration protocol starting at 0.25 mg once weekly, increasing by 0.25 mg each week until reaching a maintenance dose. Most patients reach their therapeutic dose between 1.0 mg and 2.4 mg weekly, administered as a subcutaneous injection every seven days. This gradual escalation reduces gastrointestinal side effects and allows the body to adapt to the medication.
Monthly dosing does not align with semaglutide's pharmacokinetics or clinical trial evidence. The medication reaches peak plasma concentration within 24 to 72 hours and requires consistent weekly dosing to maintain steady-state levels. Spacing doses four weeks apart would result in sub-therapeutic levels and loss of appetite-suppressing effects between injections.
Why Weekly Dosing Is Essential for Weight Loss Results
Clinical trials supporting semaglutide's weight loss efficacy used a strict weekly injection schedule. Participants in the STEP trials, which demonstrated up to 18% body weight reduction, adhered to weekly 2.4 mg doses for 68 weeks. Deviating from this schedule compromises the consistency needed for sustained appetite suppression and metabolic effects.
Semaglutide's half-life is approximately seven days, meaning the medication reaches minimum effective concentration by day seven if no new dose is administered. Waiting four weeks between injections would create cycles of high efficacy followed by near-zero drug presence, making it impossible to maintain steady weight loss momentum or prevent hunger signal return.
Compounded Semaglutide as an Affordable Weekly Alternative
PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, starting at $149 per month for consistent weekly dosing at your therapeutically optimized dose. Compounded formulations follow the same weekly injection protocol as brand-name Wegovy but provide significant cost savings without insurance requirements or membership fees. Your dose may need to go up as your body adapts; your price won't.
Patients can adjust their compounded semaglutide dose based on clinical response and tolerability while maintaining affordability. HSA and FSA accounts cover PlexusDx compounded semaglutide, increasing accessibility for those with qualifying health savings plans. PlexusDx serves all 50 states, ensuring consistent access to weekly therapy regardless of geographic location.
Optimizing Your Semaglutide Therapy with Genetic Insights
Individual responses to semaglutide vary based on genetic variations in GLP-1 receptor function, appetite regulation pathways, and metabolic genes. PlexusDx offers the Precision Peptide Genetic Test, which analyzes key genetic variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 across 14 metabolic pathways and 49 peptides. This testing reveals whether your genetics predispose you to strong or modest semaglutide response, informing optimal dosing strategy.
Genetic insights help PlexusDx providers personalize your weekly dose and determine whether adding complementary peptides or protocols might enhance results. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment, providing data-driven guidance for long-term weight management success.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take Wegovy or semaglutide once per month instead of weekly?
No. Semaglutide requires weekly injections to maintain therapeutic blood levels and appetite suppression. Monthly dosing would leave sub-therapeutic drug levels for most of the month, causing return of hunger and loss of weight loss benefits. Wegovy's clinical trials and FDA approval are based on weekly dosing schedules.
What happens if I skip a semaglutide dose or space them further apart?
Skipping or delaying doses allows semaglutide levels to drop below therapeutic thresholds within 7-14 days, reducing appetite suppression and increasing hunger. Inconsistent dosing may slow weight loss progress and make it harder to restart consistent therapy. Weekly adherence is critical for maintaining steady metabolic effects.
How much does PlexusDx compounded semaglutide cost compared to Wegovy?
PlexusDx compounded semaglutide injections start at $149 per month for consistent weekly dosing at your therapeutic dose, with no insurance required, no membership fees, and HSA/FSA eligibility. Wegovy typically costs $900-$1,400 monthly without insurance. Your dose may need to go up as you progress; your price won't.
Is compounded semaglutide as safe and effective as brand-name Wegovy?
PlexusDx compounded semaglutide comes from licensed 503A pharmacies and contains the same active pharmaceutical ingredient as Wegovy. Both follow identical weekly dosing protocols. Compounded formulations are not FDA-approved as products, but the active ingredient and dosing schedules are evidence-based and clinically established.
Can the Precision Peptide Genetic Test help me use semaglutide more effectively?
Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on after month one) analyzes 150+ genetic insights across 14 metabolic pathways to reveal your genetic predisposition to semaglutide response. Results inform whether higher doses, complementary peptides, or alternative protocols will maximize your individual weight loss outcomes based on your genetic profile.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Zepbound and Its Role in Long-Term Weight Management
How to Appeal an Insurance Denial for Wegovy or Ozempic